IO Biotech Statistics

Total Valuation

IO Biotech has a market cap or net worth of $94.21 million. The enterprise value is -$45.83 million.

Market Cap	94.21M
Enterprise Value	-45.83M

Important Dates

The next estimated earnings date is Thursday, May 9, 2024, after market close.

Earnings Date	May 9, 2024
Ex-Dividend Date	n/a

Share Statistics

IO Biotech has 65.88 million shares outstanding. The number of shares has increased by 51.10% in one year.

Shares Outstanding	65.88M
Shares Change (YoY)	+51.10%
Shares Change (QoQ)	-13.21%
Owned by Insiders (%)	2.95%
Owned by Institutions (%)	81.13%
Float	25.98M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.71
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.37, with a Debt / Equity ratio of 0.02.

Current Ratio	9.37
Quick Ratio	n/a
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -66.30% and return on invested capital (ROIC) is -67.41%.

Return on Equity (ROE)	-66.30%
Return on Assets (ROA)	-59.60%
Return on Capital (ROIC)	-67.41%
Revenue Per Employee	n/a
Profits Per Employee	-$1.27M
Employee Count	68
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, IO Biotech has paid $852,000 in taxes.

Income Tax	852,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -22.04% in the last 52 weeks. The beta is 0.50, so IO Biotech's price volatility has been lower than the market average.

Beta (1Y)	0.50
52-Week Price Change	-22.04%
50-Day Moving Average	1.61
200-Day Moving Average	1.55
Relative Strength Index (RSI)	36.70
Average Volume (30 Days)	137,719

Short Selling Information

The latest short interest is 61,842, so 0.09% of the outstanding shares have been sold short.

Short Interest	61,842
Short Previous Month	68,203
Short % of Shares Out	0.09%
Short % of Float	0.24%
Short Ratio (days to cover)	0.68

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-91.44M
Pretax Income	-85.23M
Net Income	-86.08M
EBITDA	-84.48M
EBIT	-85.23M
Earnings Per Share (EPS)	-$1.98

Full Income Statement

Balance Sheet

The company has $143.19 million in cash and $2.49 million in debt, giving a net cash position of $140.70 million or $2.14 per share.

Cash & Cash Equivalents	143.19M
Total Debt	2.49M
Net Cash	140.70M
Net Cash Per Share	$2.14
Equity / Book Value	133.16M
Book Value Per Share	2.02
Working Capital	131.54M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$71.74 million and capital expenditures -$323,000, giving a free cash flow of -$72.06 million.

Operating Cash Flow	-71.74M
Capital Expenditures	-323,000
Free Cash Flow	-72.06M
FCF Per Share	-$1.66

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

IO Biotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-51.10%
Shareholder Yield	-51.10%
Earnings Yield	-90.74%
FCF Yield	-75.96%

Analyst Forecast

The average price target for IO Biotech is $8.33, which is 482.52% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$8.33
Price Target Difference	482.52%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-32.94%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2